Floatz logo

3-(2-(4-(P-FLUOROBENZOYL)PIPERIDINO)ETHYL)-2-THIO-2,4(1H,3H)-QUINAZOLINEDIONE

Impulse Control Disorders

Hospices Civils de LyonSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Impulse Control Disorders cohort.

Asset / SponsorPhaseRating
Nalmefene
University Hospital, Clermont-Ferrand
Phase 2CCC
(18F)ALTANSERIN
Hospices Civils de Lyon
N/AD
DASB C-11
Hospices Civils de Lyon
N/AD

Same molecule, other indications

3-(2-(4-(P-FLUOROBENZOYL)PIPERIDINO)ETHYL)-2-THIO-2,4(1H,3H)-QUINAZOLINEDIONE is also rated in:

Parkinson DiseaseDormant
D
Indicative ·
28 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →